IRVINE, Calif. (AP) _ Axonics Modulation Technologies Inc. (AXNX) on Thursday reported a loss of $22.7 million in its first quarter.The Irvine, California-based company said it had a loss of 50 cents per share.The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.The medical technology company posted revenue of $48.4 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $45 million.Axonics expects full-year revenue of $238 million.Axonics shares have dropped nearly 7% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $52.26, a drop of 7% in the last 12 months._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXNX at https://www.zacks.com/ap/AXNX